2005•Zhongguo xiandai yixue/Zhongguo xiandai yixue zazhiRequires access

Assay squamous cell carcinoma antigen level in patients with esophageal cancer

Cheng Wang

Open publisher page 0 citations

Abstract

Objective: To explore the relationship between squamous cell carcinoma antigen (SCC-Ag ) level and lesions extent in the patients with esophageal cancer. Methods: The pre-treatment?after-treatment sera from 331patients with esophageal cancer from 1998 to 2002 were analyzed for the SCC-Ag level by IMX. Results: Significant correlations were found between the pre-treatment SCC-Ag level and the clinical stage, lesions length (P 0.05),no ralation was found between the pre-treatment SCC-Ag level and the pathologic classification (P 0.05). Conclusion: Pre-treatment and after-treatment measurement of serum SCC-Ag level can be used as an important index of reference to determine the seriousness of the diagnosis?pathological phase and monitor of after-treatment recurrence in patients with esophageal cancer.

About this research paper

What this paper is about

Objective: To explore the relationship between squamous cell carcinoma antigen (SCC-Ag ) level and lesions extent in the patients with esophageal cancer. Methods: The pre-treatment?after-treatment sera from 331patients with esophageal cancer from 1998 to 2002 were analyzed for the SCC-Ag level by IMX. Results: Significant correlations were found between the pre-treatment SCC-Ag level and the clinical stage, lesions length (P 0.05),no ralation was found between the pre-treatment SCC-Ag level and the pathologic classification (P 0.05). Conclusion: Pre-treatment and after-treatment measurement of serum SCC-Ag level can be used as an important index of reference to determine the seriousness of the diagnosis?pathological phase and monitor of after-treatment recurrence in patients with esophageal cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To explore the relationship between squamous cell carcinoma antigen (SCC-Ag ) level and lesions extent in the patients with esophageal cancer. Methods: The pre-treatment?after-treatment sera from 331patients with esophageal cancer from 1998 to 2002 were analyzed for the SCC-Ag level by IMX. Results: Significant correlations were found between the pre-treatment SCC-Ag level and the clinical stage, lesions length (P 0.05),no ralation was found between the pre-treatment SCC-Ag level and the pathologic classification (P 0.05). Conclusion: Pre-treatment and after-treatment measurement of serum SCC-Ag level can be used as an important index of reference to determine the seriousness of the diagnosis?pathological phase and monitor of after-treatment recurrence in patients with esophageal cancer.

Key concepts: Medicine, Pathological, Internal medicine, Esophageal cancer, Gastroenterology, Cancer, Stage (stratigraphy), Basal cell

Related papers

Back to paper searchBrowse research topicsOriginal source
Assay squamous cell carcinoma antigen level in patients with esophageal cancer — Research Paper | ScholarLens